AIM
VIVO

Aigen Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Aigen Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,760
Closed -$403K – 1162
2020
Q3 		$403K Buy
+23,760
New +$462K 0.05% 449
2020
Q2 		– Sell
-21,366
Closed -$179K – 1397
2020
Q1 		$179K Buy
21,366
+16,822
+370% +$142K 0.02% 738
2019
Q4 		$44K Buy
+4,544
New +$42.7K 0.01% 823

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aigen Investment Management's VIVO Position: Q4 2020 in Review

Aigen Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 23,760 shares — an estimated $403K sold.

Aigen Investment Management first reported a position in VIVO in Q4 2019 and held it in 3 quarters. The position peaked at $403K in Q3 2020. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • Aigen Investment Management reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 23,760 Meridian Bioscience Inc shares in Q4 2020, an estimated $403K.
  • Aigen Investment Management first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 3 quarters.
  • Aigen Investment Management's Meridian Bioscience Inc position peaked at $403K in Q3 2020.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.